PDB Short entry for 1BJB HEADER GLYCOPROTEIN 23-JUN-98 1BJB TITLE SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16], RESIDUES 1-28, 14 TITLE 2 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID BETA-PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ABETA [F16], RESIDUES 1-28; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: UNIDENTIFIED; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 32644 KEYWDS GLYCOPROTEIN, AMYLOID BETA-PEPTIDE, ALZHEIMER'S DISEASE EXPDTA SOLUTION NMR NUMMDL 14 AUTHOR S.-A.POULSEN,A.A.WATSON,D.J.CRAIK REVDAT 5 03-NOV-21 1BJB 1 REMARK SEQADV REVDAT 4 24-FEB-09 1BJB 1 VERSN REVDAT 3 01-APR-03 1BJB 1 JRNL REVDAT 2 18-NOV-98 1BJB 1 COMPND REMARK TITLE REVDAT 1 04-NOV-98 1BJB 0 JRNL AUTH S.-A.POULSEN,A.A.WATSON,D.J.CRAIK JRNL TITL SOLUTION STRUCTURES IN AQUEOUS SDS MICELLES OF TWO AMYLOID JRNL TITL 2 BETA PEPTIDES OF A BETA(1-28) MUTATED AT THE ALPHA-SECRETASE JRNL TITL 3 CLEAVAGE SITE (K16E, K16F) JRNL REF J.STRUCT.BIOL. V. 130 142 2000 JRNL REFN ISSN 1047-8477 JRNL PMID 10940222 JRNL DOI 10.1006/JSBI.2000.4267 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 JOURNAL CITATION ABOVE REMARK 4 REMARK 4 1BJB COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171823. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 296 REMARK 210 PH : 5.6 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : SDS MICELLES (100MM)/D2O, H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : AMX-500; DRX-750 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING USING NOE REMARK 210 DISTANCE CONSTRAINTS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 14 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOW ENERGY, LOW VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED FROM 2-DIMENSIONAL NMR DATA REMARK 210 ON UNLABELLED PEPTIDE REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 5 ARG A 5 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 7 PHE A 19 CB - CG - CD2 ANGL. DEV. = -4.3 DEGREES REMARK 500 13 PHE A 19 CB - CG - CD2 ANGL. DEV. = -4.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -82.11 -86.36 REMARK 500 1 GLU A 3 91.97 -162.97 REMARK 500 1 PHE A 4 -15.68 -173.87 REMARK 500 1 ARG A 5 45.83 -141.01 REMARK 500 1 HIS A 6 -48.54 -150.66 REMARK 500 1 ASP A 7 32.25 -150.13 REMARK 500 1 SER A 8 41.25 -167.31 REMARK 500 1 TYR A 10 -146.32 36.29 REMARK 500 1 GLU A 11 7.81 -164.26 REMARK 500 1 VAL A 12 -42.48 69.61 REMARK 500 1 HIS A 13 40.17 75.48 REMARK 500 1 SER A 26 36.47 -170.11 REMARK 500 2 ALA A 2 -95.09 -82.79 REMARK 500 2 GLU A 3 83.44 -156.34 REMARK 500 2 PHE A 4 -62.91 -147.95 REMARK 500 2 ASP A 7 35.20 -165.86 REMARK 500 2 SER A 8 36.88 -162.37 REMARK 500 2 HIS A 13 -2.50 76.23 REMARK 500 3 GLU A 3 7.03 -177.67 REMARK 500 3 ASP A 7 15.59 -174.39 REMARK 500 3 SER A 8 32.99 -147.04 REMARK 500 3 GLU A 11 141.72 -172.44 REMARK 500 3 VAL A 12 -59.75 -143.01 REMARK 500 3 HIS A 13 -2.13 65.31 REMARK 500 3 HIS A 14 -97.76 -89.60 REMARK 500 3 SER A 26 47.91 -167.77 REMARK 500 4 ALA A 2 -62.41 -165.74 REMARK 500 4 GLU A 3 7.23 -160.86 REMARK 500 4 HIS A 6 -54.32 -137.99 REMARK 500 4 TYR A 10 175.24 -59.32 REMARK 500 4 VAL A 12 -54.21 -138.03 REMARK 500 4 HIS A 13 -5.08 78.76 REMARK 500 4 HIS A 14 -98.65 -98.26 REMARK 500 4 SER A 26 46.80 -147.84 REMARK 500 5 PHE A 4 -26.92 -158.26 REMARK 500 5 TYR A 10 -168.71 -64.41 REMARK 500 5 HIS A 13 7.07 58.29 REMARK 500 5 HIS A 14 -76.19 -87.70 REMARK 500 5 SER A 26 27.67 42.52 REMARK 500 5 ASN A 27 -70.12 -151.25 REMARK 500 6 ALA A 2 -73.36 -71.99 REMARK 500 6 GLU A 3 21.32 -172.49 REMARK 500 6 ASP A 7 25.80 -176.33 REMARK 500 6 SER A 8 45.68 -161.59 REMARK 500 6 GLU A 11 21.25 -158.29 REMARK 500 6 VAL A 12 -34.66 72.49 REMARK 500 6 HIS A 13 38.07 74.86 REMARK 500 6 HIS A 14 -79.54 -137.56 REMARK 500 6 SER A 26 -84.10 -149.07 REMARK 500 7 GLU A 3 18.84 48.04 REMARK 500 REMARK 500 THIS ENTRY HAS 102 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1BJB A 1 28 UNP P05067 A4_HUMAN 672 699 SEQADV 1BJB GLU A 16 UNP P05067 LYS 687 ENGINEERED MUTATION SEQRES 1 A 28 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 A 28 HIS GLN GLU LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 A 28 ASN LYS HELIX 1 1 GLU A 16 VAL A 24 1 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000